MUL-20234-42265 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-24
Dose 1 — Pfizer-BioNTech
2021-04-14
Registered in v-safe
2021-04-14
Dose 2 — Pfizer-BioNTech
2021-04-14
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache, Muscle or body aches

Adult check-in
2021-04-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-04-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-28
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-05
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-12
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-19
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-05-26
Survey response — day 42, dose 2
MedDRA: Oropharyngeal pain — Feeling: Fair

Free text: Sore throat

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-05
Dose 3 — Pfizer-BioNTech
2022-04-15
Survey response — 12 months, dose 2
MedDRA: Pre-eclampsia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Postpartum preeclampsia

MedDRA releases: 2024-11 · check-in free text available
2022-04-15
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-04-20
Call 1 — Left Voicemail
2022-09-19
Dose 4 — Pfizer-BioNTech
Co-administered: Flu
2022-10-09
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-12
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-17
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-24	Pfizer-BioNTech
2	2021-04-14	Pfizer-BioNTech
3	2021-11-05	Pfizer-BioNTech	No
4	2022-09-19	Pfizer-BioNTech	Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — day 0, dose 2

2021-04-14

Systemic reaction (other): Dizziness

Release 8 — day 42, dose 2

2021-05-26

Symptoms: Sore throat

Release 11 — 12 months, dose 2

2022-04-15

Symptoms: Postpartum preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Oropharyngeal pain	✓	✓	✓
SD	Pre-eclampsia	·	·	✓
SRO	Dizziness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release